Clinical Trials
3 trialsNCT07458542 2026-03-09
Effectiveness and Safety of ONUREG (Oral Azacitidine) in Chinese Patients With Acute Myeloid Leukemia
Bristol-Myers Squibb
Active not recruiting
NCT06565975 2026-02-12
RELION
Bristol-Myers Squibb
Completed
NCT06390306 2025-06-03
The Efficacy and Safety of Third-generation TKIs Combined With Azacitidine and Bcl-2 Inhibitor in Patients With CML-MBP
Peking University People's Hospital
Recruiting